Prevalence and aggravation of cervical spine instabilities in rheumatoid arthritis during over 10 years: a prospective multicenter cohort study

We designed a prospective multicenter cohort study to clarify a long-term, > 10-year prevalence and aggravation of cervical spine instabilities in rheumatoid arthritis (RA). In 2001–2002, 634 outpatients were enrolled, and 233 (36.8%) were followed for > 10 years. Cervical spine instability wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2024-11, Vol.14 (1), p.26821-12, Article 26821
Hauptverfasser: Kanda, Yutaro, Yurube, Takashi, Hirata, Hiroaki, Sumi, Masatoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We designed a prospective multicenter cohort study to clarify a long-term, > 10-year prevalence and aggravation of cervical spine instabilities in rheumatoid arthritis (RA). In 2001–2002, 634 outpatients were enrolled, and 233 (36.8%) were followed for > 10 years. Cervical spine instability was defined as atlantoaxial subluxation (AAS, > 3-mm atlantodental interval), vertical subluxation (VS,  5 years (all, p  ≤ 0.049). While VS aggravation was associated with pre-existing AAS ( p  = 0.007) and VS ( p  = 0.002), SAS aggravation correlated with pre-existing VS ( p  = 0.002). Multivariable analysis found hand mutilating changes (odds ratio [OR] = 4.048, p  = 0.008), RA duration ≥ 5 years (OR = 3.711, p  = 0.013), C-reactive protein (CRP) level ≥ 3.8 mg/dL (OR = 2.187, p  = 0.044), and previous joint surgery (OR = 2.147, p  = 0.021) as predictors for VS aggravation. Pre-existing VS (OR = 2.252, p  = 0.024) and CRP ≥ 1.0 mg/dL (OR = 2.139, p  = 0.013) were disclosed as predictors for SAS aggravation. Low disease activity and clinical remission before the development of VS and advanced peripheral joint destruction are essential to prevent progressive cervical spine instability in RA.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-78429-9